Next Financial Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$386K Sell
4,417
-230
-5% -$19.1K 0.03% 645
2021
Q3
$380K Buy
4,647
+590
+15% +$53.1K 0.03% 584
2021
Q2
$370K Buy
4,057
+290
+8% +$25.8K 0.03% 581
2021
Q1
$322K Sell
3,767
-45
-1% -$4.04K 0.03% 600
2020
Q4
$360K Buy
3,812
+247
+7% +$21.6K 0.03% 491
2020
Q3
$310K Buy
3,565
+34
+1% +$2.94K 0.03% 491
2020
Q2
$308K Sell
3,531
-70
-2% -$6.04K 0.04% 407
2020
Q1
$297K Buy
3,601
+239
+7% +$21.3K 0.04% 419
2019
Q4
$319K Buy
3,362
+142
+4% +$12.7K 0.03% 503
2019
Q3
$280K Sell
3,220
-497
-13% -$44.6K 0.03% 530
2019
Q2
$339K Buy
3,717
+695
+23% +$58.8K 0.04% 479
2019
Q1
$260K Sell
3,022
-736
-20% -$59.1K 0.07% 298
2018
Q4
$289K Buy
3,758
+1,557
+71% +$121K 0.06% 312
2018
Q3
$170K Sell
2,201
-2,310
-51% -$171K 0.08% 234
2018
Q2
$305K Sell
4,511
-1,801
-29% -$124K 0.12% 196
2018
Q1
$457K Buy
6,312
+1,541
+32% +$117K 0.1% 226
2017
Q4
$359K Sell
4,771
-1,674
-26% -$126K 0.15% 170
2017
Q3
$497K Sell
6,445
-3,156
-33% -$238K 0.14% 164
2017
Q2
$718K Sell
9,601
-113
-1% -$8.01K 0.18% 133
2017
Q1
$670K Sell
9,714
-1,872
-16% -$125K 0.19% 124
2016
Q4
$756K Buy
11,586
+377
+3% +$24.5K 0.13% 175
2016
Q3
$793K Buy
11,209
+4,617
+70% +$336K 0.14% 158
2016
Q2
$487K Buy
6,592
+144
+2% +$9.95K 0.15% 145
2016
Q1
$418K Buy
6,448
+346
+6% +$23.5K 0.15% 151
2015
Q4
$470K Sell
6,102
-335
-5% -$26.6K 0.18% 136
2015
Q3
$530K Sell
6,437
-136
-2% -$12.1K 0.19% 118
2015
Q2
$579K Sell
6,573
-469
-7% -$43K 0.2% 117
2015
Q1
$622K Sell
7,042
-251
-3% -$22.3K 0.2% 126
2014
Q4
$606K Sell
7,293
-4,279
-37% -$355K 0.2% 118
2014
Q3
$976K Buy
11,572
+11,505
+17,172% +$931K 0.19% 123
2014
Q2
$5K Buy
+67
New +$5.27K ﹤0.01% 931

Other funds holding NVS

Next Financial Group's NVS Position: Q4 2021 in Review

Next Financial Group reduced its Novartis (NVS) stake by 4.9% in Q4 2021, selling an estimated $19.1K and leaving 4,417 shares worth $386K. The position accounts for 0.03% of the portfolio, ranked #645.

Next Financial Group first reported a position in NVS in Q2 2014 and has held it in 31 quarters since. The position peaked at $976K in Q3 2014. 1,146 funds tracked by Wall St. Rank hold NVS as of Q4 2021.

  • Next Financial Group held 4,417 shares of Novartis worth $386K as of Q4 2021.
  • Next Financial Group sold 230 Novartis shares in Q4 2021, an estimated $19.1K.
  • Novartis made up 0.03% of Next Financial Group's portfolio in Q4 2021, its #645 holding.
  • Next Financial Group first reported a position in Novartis in Q2 2014 and has held it in 31 quarters since.
  • Next Financial Group's Novartis position peaked at $976K in Q3 2014.
  • 1,146 funds tracked by Wall St. Rank held Novartis as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.